Rheumatoid Arthritis News

The risk-benefit profile of upadacitinib for rheumatoid arthritis “remains favorable” through 5 years, according to data published in The Journal of Rheumatology.

In this episode, we dive into the story of aspirin and the development of ibuprofen, ending with the experiments that showed the mechanism of how aspirin actually works.

A long-term safety analysis of filgotinib for moderate-to-severe rheumatoid arthritis demonstrated potential dose-dependent risks for herpes zoster, malignancies and all-cause mortality in patients aged 65 and older, according to data.

Rheumatoid arthritis and fibromyalgia are among the most common comorbidities identified in patients following a diagnosis of osteoarthritis, according to data presented at the EULAR 2024 Congress.

A new clinic at The Ohio State University — Arthur G. James Cancer Hospital and Richard J. Solove Research Institute and Pelotonia Institute for Immuno-Oncology seeks to minimize the autoimmune effects of immunotherapy cancer treatment.

A digital app was effective at improving mental health outcomes like anxiety and depression in a cohort of patients with rheumatoid arthritis, according to a speaker at EULAR 2024 Congress.

The ability to view laboratory results, track symptoms and sharing them with a provider were rated as the most useful potential app functions by patients with rheumatic and musculoskeletal diseases, according to data.

Secondhand cigarette smoke increases the risk for developing rheumatoid arthritis, but only in cases of low-level exposure, according to data published in Scientific Reports.

In this Healio video exclusive, Michael S. Garshick, MD, MS, discusses the role of inflammation in heart disease and how it has become a treatment target.

Older adults with arthritis demonstrate poorer nutritional risk scores, and increased risks for poor nutrition, whether they have functional impairment or not, vs. those without arthritis, according to data published in Scientific Reports.